80
Participants
Start Date
November 29, 2023
Primary Completion Date
April 1, 2026
Study Completion Date
April 1, 2026
Briquilimab
Subcutaneous Administration
Placebo
Placebo Comparator
WITHDRAWN
Site 114, Philadelphia
RECRUITING
Site 104, Chevy Chase
RECRUITING
Site 121, White Marsh
RECRUITING
Site 101, Baltimore
WITHDRAWN
Site 102, North Charleston
RECRUITING
Site 113, Miami
RECRUITING
Site 116, Tampa
RECRUITING
Site 118, Birmingham
RECRUITING
Site 103, Cincinnati
RECRUITING
Site 110, Indianapolis
RECRUITING
Site 124, Springfield
WITHDRAWN
Site 107, St Louis
RECRUITING
Site 122, Overland Park
RECRUITING
Site 123, Lafayette
WITHDRAWN
Site 125, Baton Rouge
RECRUITING
Little Rock Allergy & Asthma Clinical Research Center, Little Rock
WITHDRAWN
Site 112, Dallas
RECRUITING
Site 109, Boise
RECRUITING
Site 111, Murray
RECRUITING
Site 105, San Diego
WITHDRAWN
Site 117, Fremont
RECRUITING
Site 115, Seattle
RECRUITING
Site 201, Berlin
RECRUITING
Site 203, Bonn
RECRUITING
Site 211, Buxtehude
RECRUITING
Site 209, Dresden
RECRUITING
Site 208, Frankfurt
RECRUITING
Site 207, Hanover
RECRUITING
Site 206, Lübeck
RECRUITING
Site 202, Marburg
RECRUITING
Site 210, München
RECRUITING
Site 204, Münster
Lead Sponsor
Jasper Therapeutics, Inc.
INDUSTRY